NewsCase StudiesEvents

GlaxoSmithKline investing in Greece

Also in the news...

Switzerland: providing services and travelling for business

Guidance for UK businesses on rules for selling services to Switzerland.

UK lands trade deal with South Korea to boost jobs and exports

UK lands momentous trade deal with South Korea to boost jobs and exports

New laws bring the world of work into the 21st century

Over 15 million people across the UK are expected to benefit as the Employment Rights Act receives Royal Assent.

Brilliant Borders: Kenya's Customs goes digital

A new app will save time and money for big businesses and small traders alike, as a longstanding Kenya-UK partnership further improves cross-border trade.

Yorkshire family brewery taps into new export opportunities with Government guarantee

UKEF support helps Wold Top brewery to expand its exports into new markets.

GlaxoSmithKline investing in Greece

Back to News

The leading UK pharmaceutical company, Glaxo Smithkline (GSK) announced new €2.2 million investment in Greece, at the British Residence.

This investment will enable secondary packaging for 4 over-the-counter products. This will take place at FAMAR’s facilities, in the context of a long-term cooperation between the two companies. Production is expected to begin before the end of the year and will reinforce the exporting capacity of GSK Greece, as 98% of the new production will be exported to 32 countries.

The Minister for Development, Costis Hatzidakis, opened the event alongside the host, the British Ambassador, John Kittmer, who said:

I am delighted that GSK, a great British company, has decided to increase its investment in Greece. This decision shows the importance of foreign direct investment to Greece’s future and the importance of Greece’s efforts to improve the business environment.

gov.uk

You are not logged in!

Please login or register to ask our experts a question.

Login now or register.